<DOC>
	<DOC>NCT00534248</DOC>
	<brief_summary>This study will look at how well Zostavax™ works in preventing shingles in participants ages 50-59 years old.</brief_summary>
	<brief_title>Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Must be between 50 59 years of age No fever on day of vaccination Females of reproductive potential must be willing to use acceptable form of birth control Have received chicken pox or shingles vaccine Have already had shingles Have recently had another vaccination Pregnant or breast feeding. Have participated in another research study in the last 30 days You are taking certain antiviral drugs History of allergic reaction to any vaccine component, including gelatin or neomycin</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>